⌘K

Login Start Free

Home/Filings/4/0001209191-22-043767

4//SEC Filing

Hexter Joshua 4

Accession 0001209191-22-043767

CIK 0001176309other

View on SEC.gov Company Profile

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 8:00 PM ET

Size

4.9 KB

Accession

0001209191-22-043767

Insider Transaction Report

Form 4

Period: 2022-07-28

ORAMED PHARMACEUTICALS INC.ORMP

COO & CBO

Transactions

Award
Common Stock
2022-07-28+42,000→ 166,333 total

Footnotes (1)

[F1]Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 14,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1

filerCIK 0001573235

Filing Metadata

Form type: 4
Filed: Jul 31, 8:00 PM ET
Accepted: Aug 1, 8:00 PM ET
Size: 4.9 KB

View on SEC.gov